These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22627847)

  • 1. Inhibition of common cold-induced aggravation of childhood asthma by leukotriene receptor antagonists.
    Yoshihara S; Fukuda H; Abe T; Nishida M; Yamada Y; Kanno N; Arisaka O
    Allergol Int; 2012 Sep; 61(3):405-10. PubMed ID: 22627847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
    Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
    Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of leukotriene receptor antagonists in preventing common cold-like symptoms in bronchial asthma patients.
    Horiguchi T; Ohira D; Kobayashi K; Hirose M; Miyazaki J; Kondo R; Tachikawa S
    Allergol Int; 2007 Sep; 56(3):263-7. PubMed ID: 17582209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
    Zsigmond G; Novák Z; Kósa L
    Orv Hetil; 2004 Nov; 145(48):2431-5. PubMed ID: 15638037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical treatment strategies for childhood asthma.
    Carlsen KH; Carlsen KC
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):168-76. PubMed ID: 18317028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of early asthma in preschool-aged children.
    Bacharier LB; Guilbert TW
    J Allergy Clin Immunol; 2012 Aug; 130(2):287-96; quiz 297-8. PubMed ID: 22664162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchial obstruction: a limited, out-of-fashion approach to measure treatment efficacy in childhood asthma?
    Silvestri M; Bellodi S; Rossi GA
    J Allergy Clin Immunol; 2006 Feb; 117(2):474-5; author reply 475-6. PubMed ID: 16461158
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.
    Dorais M; Blais L; Chabot I; LeLorier J
    J Asthma; 2005 Jun; 42(5):385-93. PubMed ID: 16036414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene antagonists as first-line or add-on asthma-controller therapy.
    Price D; Musgrave SD; Shepstone L; Hillyer EV; Sims EJ; Gilbert RF; Juniper EF; Ayres JG; Kemp L; Blyth A; Wilson EC; Wolfe S; Freeman D; Mugford HM; Murdoch J; Harvey I
    N Engl J Med; 2011 May; 364(18):1695-707. PubMed ID: 21542741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled steroid therapy and hospitalization for bronchial asthma: trend in Tokushima University Hospital.
    Yanagawa H; Shiraga M; Nakamura Y; Azuma M; Yoneda K; Ogawa H; Kitamuro C; Maeda K; Miki M; Matsumori Y; Sugita A; Hashimoto S; Hara C; Tani K; Sone S
    J Med Invest; 2003 Feb; 50(1-2):72-7. PubMed ID: 12630571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of childhood asthma.
    Balachandran A; Shivbalan S; Subramanyam L
    Indian J Pediatr; 2001 Sep; 68 Suppl 4():S12-6. PubMed ID: 11980463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene antagonists. Do they offer new hope for asthmatics?
    Thien F
    Aust Fam Physician; 2000 Jun; 29(6):547-51. PubMed ID: 10863810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast in childhood asthma.
    Mehta PN
    Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukotriene modifiers in the treatment of asthma in children.
    del Giudice MM; Pezzulo A; Capristo C; Alterio E; Caggiano S; de Benedictis D; Capristo AF
    Ther Adv Respir Dis; 2009 Oct; 3(5):245-51. PubMed ID: 19822630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of suplatast tosilate on antileukotriene non-responders with mild-to-moderate persistent asthma.
    Wada M; Nagata S; Kudo T; Shimizu T; Yamashiro Y
    Allergol Int; 2009 Sep; 58(3):389-93. PubMed ID: 19542765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.